HCW Biologics Inc. (NASDAQ: HCWB)
$0.69
-0.0140 ( -2.00% ) 4.7K
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
Market Data
Open
$0.69
Previous close
$0.70
Volume
4.7K
Market cap
$24.21M
Day range
$0.65 - $0.71
52 week range
$0.55 - $2.32
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 49 | Aug 11, 2023 |
8-k | 8K-related | 14 | Aug 11, 2023 |
10-q/a | Quarterly Reports | 49 | Aug 10, 2023 |